Sigyn Therapeutics, Inc. (SIGY)

Sigyn Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	0.01	0.01	0.34	0.08	0
Cash & Cash Equivalents	0.01	0.01	0.34	0.08	0
Cash Growth	39.90%	-97.55%	303.97%	16780.40%	-93.33%
Receivables	0	0	0	0	0
Inventory	0.05	0.05	0.05	0.59	0.59
Other Current Assets	0.06	0.01	0	0	0
Total Current Assets	0.12	0.07	0.39	0.67	0.59
Property, Plant & Equipment	0.18	0.24	0.29	0	0
Intangible Assets	0	0	0.01	0.02	0.05
Other Long-Term Assets	0.02	0.02	0.02	0	0
Total Long-Term Assets	0.2	0.26	0.32	0.02	0.05
Total Assets	0.32	0.33	0.71	0.69	0.64
Accounts Payable	0.46	0.33	0.04	0.02	0.01
Deferred Revenue	0.87	0	0	0.06	1.17
Current Debt	2.27	1.69	0.69	0.52	1.9
Other Current Liabilities	0	0.03	0	0	0.03
Total Current Liabilities	3.61	2.05	0.73	0.59	3.1
Long-Term Debt	0.13	0.19	0.24	0	0
Total Long-Term Liabilities	0.13	0.19	0.24	0	0
Total Liabilities	3.73	2.24	0.97	0.59	3.1
Total Debt	2.4	1.88	0.93	0.52	1.9
Debt Growth	27.72%	101.01%	80.06%	-72.70%	3.51%
Common Stock	0	0	0	0	0.01
Retained Earnings	-11.34	-7.2	-4.27	-1.26	-16.08
Comprehensive Income	0	0	0	-0	-0
Shareholders' Equity	-3.41	-1.9	-0.26	0.1	-2.46
Total Liabilities and Equity	0.32	0.33	0.71	0.69	0.64
Net Cash / Debt	-2.39	-1.87	-0.59	-0.43	-1.9
Net Cash Per Share	-2.17	-0.05	-0.02	-0.06	-3.51
Working Capital	-3.49	-1.98	-0.34	0.08	-2.51
Book Value Per Share	-3.10	-0.05	-0.01	0.01	-4.54

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.